Overview FIRDAPSE. The outcome of patent litigation with Paragraph IV challengers is always uncertain and there can be no assurance as to whether we will prevail in this litigation. Other Litigation From time to time we may become involved in legal proceedings arising in the ordinary course of business. Other than as set forth above, we believe that there is no litigation pending at this time that could have, individually or in the aggregate, a material adverse effect on our results of operation...
Q2 FY2026 — expected 2026-09-16
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-25 | 2025-12-31 | 0001193125-26-071525 | EDGAR | 94K words |
| 2025-02-26 | 2024-12-31 | 0000950170-25-027714 | EDGAR | — |
| 2024-02-28 | 2023-12-31 | 0001193125-24-050908 | EDGAR | — |
| 2023-03-15 | 2022-12-31 | 0001193125-23-071299 | EDGAR | — |
| 2022-03-16 | 2021-12-31 | 0001193125-22-077228 | EDGAR | — |
| 2021-03-15 | 2020-12-31 | 0001193125-21-081545 | EDGAR | — |
| 2020-03-16 | 2019-12-31 | 0001193125-20-075048 | EDGAR | — |
| 2019-03-18 | 2018-12-31 | 0001193125-19-078253 | EDGAR | — |
| 2018-03-14 | 2017-12-31 | 0001193125-18-082292 | EDGAR | — |
| 2017-03-15 | 2016-12-31 | 0001193125-17-083667 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-05 | 2025-09-30 | 0001193125-25-266854 | EDGAR | 38K words |
| 2025-08-06 | 2025-06-30 | 0000950170-25-104000 | EDGAR | — |
| 2025-05-07 | 2025-03-31 | 0000950170-25-065652 | EDGAR | — |
| 2024-11-06 | 2024-09-30 | 0000950170-24-122282 | EDGAR | — |
| 2024-08-07 | 2024-06-30 | 0000950170-24-092745 | EDGAR | — |
| 2024-05-08 | 2024-03-31 | 0001193125-24-134195 | EDGAR | — |
| 2023-11-08 | 2023-09-30 | 0001193125-23-273506 | EDGAR | — |
| 2023-08-09 | 2023-06-30 | 0001193125-23-207344 | EDGAR | — |
| 2023-05-10 | 2023-03-31 | 0001193125-23-140701 | EDGAR | — |
| 2022-11-09 | 2022-09-30 | 0001193125-22-281202 | EDGAR | — |
| 2022-08-09 | 2022-06-30 | 0001193125-22-216148 | EDGAR | — |
| 2022-05-10 | 2022-03-31 | 0001193125-22-146274 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-07-16 | 0001193125-26-304984 | EDGAR | — |
| 2026-03-18 | 0001193125-26-114306 | EDGAR | 0K words |
| 2026-02-25 | 0001193125-26-071702 | EDGAR | — |
| 2026-01-12 | 0001193125-26-009822 | EDGAR | — |
| 2025-11-05 | 0001193125-25-267038 | EDGAR | — |
| 2025-10-01 | 0001193125-25-226837 | EDGAR | — |
| 2025-08-25 | 0001193125-25-187733 | EDGAR | — |
| 2025-08-07 | 0001193125-25-175477 | EDGAR | — |
| 2025-08-06 | 0001193125-25-174540 | EDGAR | — |
| 2025-08-04 | 0001193125-25-172653 | EDGAR | — |
330 total filings indexed. 298 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001369568 |
| Ticker | CPRX |
| Exchange | Nasdaq |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
| Website | https://www.catalystpharma.com |
| Listed | 2006-11-08 |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/CPRX (~200 tokens, structured JSON with cryptographic provenance)